What is Shrikant Bhamre's specialty?

Shrikant Bhamre (NPI 1669429569) is a Medicare-billing provider whose primary specialty is Ophthalmology in New York, NY.

Where does Shrikant Bhamre practice?

Shrikant Bhamre practices in New York, NY, based on the location reported in the CMS Medicare provider datasets for NPI 1669429569.

How much does Medicare pay Shrikant Bhamre?

Shrikant Bhamre (NPI 1669429569) received approximately $922 in total Medicare Part B payments, serving 13 beneficiaries, per the CMS Medicare Physician & Other Practitioners dataset.

PROVIDER PROFILE · NPI 1669429569

Shrikant BhamreMD

OphthalmologyNew York, NYI

MEDICARE UTILIZATION · PART B · 2024

No data available for this provider in 2024.

PRESCRIBING · PART D · 2024

No data available for this provider in 2024.

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

REFERRAL NETWORK

Where Shrikant Bhamre's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 6 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
TERENCE CARDINAL COOKE HEALTH CARE CENTER	125	282
Bioreference Health, Llc Clinical Laboratory · Elmwood Park, NJ	59	111
Joseph Winik Internal Medicine · New York, NY	39	48
VIVIANO, ANN	21	47
Mekonnen Abebe Internal Medicine · New York, NY	15	21
TRANSCARE NEW YORK, INC.	13	16

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history